HDFC Bank records 20% rise in Q4 profit
Good morning!
Here are the top stories to start your day.
For more updates on F&O, click here.
⭐HDFC Bank records 20% rise in Q4 profit
The private lender saw its March quarter net profit rise 19.8% YoY to ₹12,047 crore on the back of higher core income and lower provisions. Its net interest income increased by 23.7% YoY to ₹23,351 crore. The company’s board also recommended a dividend of ₹19 per share for its shareholders.
⭐** Infosys Q4: Revenues up, but challenges ahead in FY24**
The IT giant reported an 8% YoY growth in consolidated net profit to ₹6,128 crore during the March quarter. During the same period, its revenue grew by 16% YoY to ₹37,441 crore. The company also declared a final dividend of ₹17.50 per share. Meanwhile, the company gave conservative sales guidance of 4-7% for FY24. Click ** here** to get a complete overview of Infosys results.
⭐ Zydus Lifesciences gets USFDA nod
The pharma company has received USFDA approval to manufacture and market a new drug, isoproterenol hydrochloride injection. As per IQVIA, this solution has annual sales of over $28 million in the US market.
Global markets (at 9:00 AM today)
| Indices | Today's movement |
| --
| --
- | --
- |
| SGX Nifty | ▼ 0.54% |
| Nikkei 225 (Japan) | ▼ 0.06% |
| Hang Seng (Hong Kong) | **▲**0.21% |
| SSE Composite (China) | **▲**0.98% |
| Dow Jones (US) (April 14) | ▼ 0.42% |
| NYSE (US) (April 14) | ▼ 0.19% |
| Nasdaq (US) (April 14) | ▼ 0.35% |
| S&P 500 (US) (April 14) | ▼ 0.21% |
Fact of the day
** India’s trade deficit** widens to $19.7 billion in March, higher than the $17.4 billion recorded in the previous month
Source: ** Business Standard**